Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Why Are These Stocks Surging Today?

With all three indexes again down 1% or more on Thursday and fears of a potential 2008 replay rising, shares of MakeMyTrip Limited (NASDAQ:MMYT), Arotech Corporation (NASDAQ:ARTX), TherapeuticsMD Inc (NYSEMKT:TXMD), Barrick Gold Corporation (USA) (NYSE:ABX), and Chico’s FAS, Inc. (NYSE:CHS) are surging. Let’s take a closer look at why investors are buying.

Given that Insider Monkey has done a lot of research into what the smart money likes and doesn’t like, let’s also analyze relevant hedge fund sentiment toward these stocks. We pay attention to hedge funds’ moves because our research has shown that hedge funds are extremely talented at picking stocks on the long side of their portfolios. It is true that hedge fund investors have been underperforming the market in recent years. However, this was mainly because hedge funds’ short stock picks lost a ton of money during the bull market that started in March 2009. Hedge fund investors also paid an arm and a leg for the services that they received. We have been tracking the performance of hedge funds’ 15 most popular small-cap stock picks in real time since the end of August 2012. These stocks have returned 102% since then and outperformed the S&P 500 Index by around 53 percentage points (see the details here). That’s why we believe it is important to pay attention to hedge fund sentiment; we also don’t like paying huge fees.

Leading indian travel company MakeMyTrip Limited (NASDAQ:MMYT) is 27.7% higher today after the company announced that International, Ltd. (ADR) (NASDAQ:CTRP) will invest $180 million in the company through convertible bonds. In addition, MakeMyTrip has given Ctrip permission to acquire up to 26.6% of its outstanding shares through convertibles and open market purchases. CEO Deep Kalra said:

“We are delighted to have Ctrip invest in us. Ctrip is the dominant market leader in the online travel market in China. We believe there are many similarities in the Indian and Chinese online travel markets and we expect this strategic relationship between two market leaders to be mutually beneficial.”

A total of 12 elite funds from our database owned 15.40% of MakeMyTrip Limited (NASDAQ:MMYT)’s float at the end of the third quarter.

Follow Makemytrip Limited (NASDAQ:MMYT)
Trade (NASDAQ:MMYT) Now!

Shares of nano-cap Arotech Corporation (NASDAQ:ARTX) surged by 17% on technical buying today, as bullish traders bet that the stock’s recent rally will continue. Arotech Corporation (NASDAQ:ARTX) recently closed above a key technical average and some investors hope that management can turn the company around. Due to its small market cap, not many elite funds own the stock. Our data show that only two of the around 730 elite funds that we track were long Arotech at the end of September.

Follow Arotech Corp (NASDAQ:ARTX)
Trade (NASDAQ:ARTX) Now!

On the next page, we examine TherapeuticsMD Inc, Barrick Gold Corporation (USA), and Chico’s FAS Inc.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.